Research Article

Incidence and Complications of Atrial Fibrillation in a Low Socioeconomic and High Disability United States (US) Population: A Combined Statistical and Machine Learning Approach

Table 3

Odds ratios “OR” (95% CI) for relationships between baseline characteristics of comorbid history/demographic variables/Medicaid group categories and atrial fibrillation status group as an outcome, with cost threshold (of $2000 or more in the year prior to index date or the equivalent for non-AF cases) as a model feature.

VariableLevelOR95% CL

Congestive heart failure1 vs 02.382.242.53
Hypertension1 vs 01.561.481.64
Diabetes mellitus1 vs 01.181.121.24
Stroke1 vs 01.301.211.40
Vascular disease1 vs 01.211.141.29
Valvular disease1 vs 01.621.521.73
Coronary artery disease1 vs 01.361.281.44
Chronic sleep apnea1 vs 01.161.041.29
Chronic kidney disease1 vs 01.361.281.45
Chronic pulmonary obstructive disease/bronchiectasis1 vs 01.531.461.61
Major bleeding1 vs 01.201.121.28
Cognitive impairment1 vs 0
Liver disease1 vs 01.171.101.24
Anemia1 vs 01.291.231.36
Depression1 vs 01.191.131.24
Lipid disorders1 vs 00.930.890.97
Spondylosis and intervertebral discs1 vs 01.131.081.18
Osteoarthritis1 vs 01.091.041.15
Hyperthyroidism1 vs 01.241.061.44
Metabolic syndrome1 vs 00.580.430.77
Asthma1 vs 00.700.650.75
Gender1 vs 00.740.710.77

Age group4 vs 07.016.417.66
3 vs 04.173.824.56
2 vs 02.282.142.44
1 vs 01.721.611.83

Medicaid group6 vs 01.621.481.78
5 vs 02.432.242.65
4 vs 01.281.161.40
3 vs 01.541.441.65
2 vs 01.551.451.65
1 vs 03.222.933.52

Cost threshold (1 year prior)1.621.541.71

Note: 1—The presence of comorbid condition; 0—the absence of comorbid condition; 75–90 (4) vs 18–44 years (0); 65–74 (3) vs 18–44 years (0); 55–64 (2) vs 18–44 years (0); 45–54 (1) vs 18–44 years (0); LTSS—duals (6) vs TANF (0); ABD—duals (5) vs TANF (0); LTSS—nondual (4) vs TANF (0); ABD—nondual (3) vs TANF (0); two groups (2) vs TANF (0); family care (1) vs TANF (0); model feature based on cost threshold of 1 year prior for $2000 or more (1 or > $2000; 0 otherwise); TANF group (1 or > $8750 that is applied for AF cohort only; 0 otherwise); 0—absence of comorbid condition, CL—confidence limits, and C index = 0.822. Data are based on the entire population.